-
'Free France': Macron reveals name of Europe's largest warship
-
Oil surges as Iran gas facilities hit, stocks slide
-
Foreign press group slams Israeli police for breaking journalist's wrist
-
McIlroy happy with back injury recovery as Masters looms
-
Vinicius 'should be loved by everyone' says Donnarumma after celebration row
-
Iran was not rebuilding nuclear enrichment, US intelligence finds
-
Carrick urges England boss Tuchel to call up United trio
-
Three sporting champions to be stripped of titles for non-doping reasons
-
Chilean GDP beats 2025 forecast despite mining dip
-
Storms, warm seas drove sudden drop in Antarctic ice: study
-
Aston Villa want to be more than a 'maybe team' in quest for Europa League
-
Trump administration takes steps to curb energy cost hikes
-
Vaccines facing misinformation spike: WHO experts
-
Pakistan announces Eid 'pause' in conflict with Afghanistan
-
'Happened so fast': UK students panicked by meningitis outbreak
-
WNBA, players union agree 'transformative' labor deal: reports
-
Global music market grows, calls for AI compensation: industry body
-
Maiduguri bombings follow surge of jihadist violence in Nigeria
-
Belgian court suspends TotalEnergies climate trial
-
Troubled waters: Thai fishermen marooned by rising fuel costs
-
Doku adamant Man City still have plenty to play for after Champions League exit
-
Afghanistan vows to avenge deadly Kabul bombing but says open to talks
-
Nigerian president meets royals on 'historic' UK state visit
-
South Lebanon residents flee death and destruction
-
Buttler ready to continue England career despite 'poor' T20 World Cup
-
Why convoys cannot fully protect oil tankers from Iran attacks
-
UK PM leads efforts to halt deadly meningitis spread
-
EU lawmakers back ban on sexualised AI deepfakes
-
Stripping Senegal of AFCON title a 'disgrace for Africa' say fans
-
Under Hezbollah fire, people in north Israel hope for better days
-
Iran women's football team cross Turkish border to head home: AFP
-
Fear in central Beirut as Israel strikes, with and without warning
-
'France is wild': Macron to unveil name of Europe's largest warship
-
Arsenal's Trossard says Leverkusen win ideal ahead of League Cup final
-
Israel conducts wave of strikes on Beirut
-
Seven-year term sought for Norway princess's son for alleged rapes
-
US govt says Anthropic AI an 'unacceptable risk' to military
-
Head of victorious Nepal party hails 'win for the country'
-
UN maritime body kicks off emergency talks on Mideast shipping
-
Israel says killed Iran intel chief, tells military to hunt down officials
-
China tech giant Tencent bets on AI agents
-
AFCON stripping of Senegal's title a 'disgrace for Africa' say fans
-
Japan thrash South Korea 4-1 to set up Women's Asian Cup final with Australia
-
Fernandez uncertain over Chelsea future after Champions League exit
-
Iran women's football team arrive in eastern Turkey, heading home
-
Russia slams Oscar-winning anti-Putin documentary
-
Mass burials expected for victims of Kabul drug rehab centre strike
-
Celtic keeper Schmeichel fears shoulder injury could end his career
-
Israelis shelter with pets from threat of Iran missiles
-
Deadly strikes across Mideast as Iran vows revenge on slain security chief
Court to hear lawsuit seeking to ban abortion pill in US
A Texas judge favored by anti-abortion activists will hear arguments Wednesday in an unprecedented challenge to the legality of a widely-used abortion pill.
US District Court Judge Matthew Kacsmaryk announced Monday the hearing on a lawsuit alleging the US Food and Drug Administration (FDA) should never have approved the "dangerous" prescription drug Mifepristone in 2000.
Mifepristone, one component of a two-drug regimen used for medication abortion, has been used by an estimated 5.6 million women to terminate pregnancies since its approval, according to the FDA.
It is can be used in the United States up to 10 weeks of pregnancy.
The pro-abortion rights Guttmacher Institute estimates that more than half of all abortions involve the use of mifepristone.
But the Alliance Defending Freedom, a Christian advocacy group, sued the FDA saying its approval "disavow(ed)" science, "ignored" potential health impacts and "disregarded" the complications that can arise with using mifepristone.
"The FDA failed America's women and girls when it chose politics over science and approved chemical abortion drugs for use in the United States," they said.
Galvanized by the Supreme Court's ruling in June that overturned the constitutional right to an abortion, abortion opponents have now set their sights on obtaining prohibitions on mifepristone.
Already the treatment has been halted in some 15 states which have banned all abortion since the 2022 Supreme Court decision.
The Texas suit seeks to block it nationally by overturning the FDA's approval of the drug.
The FDA has urged the judge to reject the request.
"The public interest would be dramatically harmed by effectively withdrawing from the marketplace a safe and effective drug that has lawfully been on the market for 22 years," it said.
Kacsmaryk was targeted by the plaintiffs to hear the case due to his deep conservative Christian beliefs and previous anti-abortion stance.
He had been expected since February 24 to issue a ruling in the case, which asks him to suspend the FDA's approval of the drug while the lawsuit proceeds.
Apparently fearing protestors descending on the courthouse in Amarillo, Texas, Kacsmaryk originally sought to keep the hearing secret until the last minute, but it leaked to media.
If he does order the suspension, it could leave pregnant women with the alternative of using only misoprostol, the second pill in the medication abortion treatment.
But using misoprostol alone is more physically traumatic than the two-pill procedure, and some fear doctors might be unwilling to prescribe it alone.
If mifepristone is banned, "access to medication abortion would end across the country -- even in those states where abortion rights are protected," the Center for Reproductive Rights said.
A.Jones--AMWN